✨ Your Portfolio is fetched and updated from zerodha.
Micro Miscellaneous

EVOQ Remedies Ltd.

EVOQ

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹9 Cr.
P/E
97.05

EVOQ Remedies Ltd.

  • EVOQ Remedies
  • JFL Life Sciences
  • Deccan Health Care
FAQs on EVOQ Remedies Ltd. Shareprice

EVOQ Remedies has given lower returns compared to its competitors.
EVOQ Remedies has grown at ~-50.85% over the last 2yrs while peers have grown at a median rate of -1.22%

EVOQ Remedies is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of EVOQ Remedies is 97.05, while 3 year average PE is 33.11.
Also latest EV/EBITDA of EVOQ Remedies is 0 while 3yr average is 5.63.

View FAQ's On Business
Growth Table
  • EVOQ Remedies Ltd.
  • JFL Life Sciences
  • Deccan Health Care
Balance Sheet
  • EVOQ Remedies Ltd.
  • JFL Life Sciences
  • Deccan Health Care
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • EVOQ Remedies Ltd.
  • JFL Life Sciences
  • Deccan Health Care
Cash Flow
  • EVOQ Remedies Ltd.
  • JFL Life Sciences
  • Deccan Health Care
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • EVOQ Remedies Ltd.
  • JFL Life Sciences
  • Deccan Health Care
Quarterly Results
  • EVOQ Remedies Ltd.
  • JFL Life Sciences
  • Deccan Health Care
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on EVOQ Remedies Ltd. Financials

EVOQ Remedies balance sheet is weak and might have solvency issues

The net debt of EVOQ Remedies is decreasing.
Latest net debt of EVOQ Remedies is -₹0.21 Crs as of Mar-25.
This is less than Mar-24 when it was ₹4.05 Crs.

The profit is oscillating.
The profit of EVOQ Remedies is ₹0.45 Crs for Mar 2024, ₹1.62 Crs for Mar 2023 and ₹1.09 Crs for Mar 2022

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
EVOQ Remedies latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Inventory, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech